Unknown

Dataset Information

0

Bepridil decreases A? and calcium levels in the thalamus after middle cerebral artery occlusion in rats.


ABSTRACT: Alzheimer's disease (AD) and cerebral ischaemia share similar features in terms of altered amyloid precursor protein (APP) processing and ?-amyloid (A?) accumulation. We have previously shown that A? and calcium deposition, and ?-secretase activity, are robustly increased in the ipsilateral thalamus after transient middle cerebral artery occlusion (MCAO) in rats. Here, we investigated whether the non-selective calcium channel blocker bepridil, which also inhibits ?-secretase cleavage of APP, affects thalamic accumulation of A? and calcium and in turn influences functional recovery in rats subjected to MCAO. A 27-day bepridil treatment (50 mg/kg, p.o.) initiated 2 days after MCAO significantly decreased the levels of soluble A?40, A?42 and calcium in the ipsilateral thalamus, as compared with vehicle-treated MCAO rats. Expression of seladin-1/DHCR24 protein, which is a potential protective factor against neuronal damage, was decreased at both mRNA and protein levels in the ipsilateral thalamus of MCAO rats. Conversely, bepridil treatment restored seladin-1/DHCR24 expression in the ipsilateral thalamus. Bepridil treatment did not significantly affect heme oxygenase-1- or NAD(P)H quinone oxidoreductase-1-mediated oxidative stress or inflammatory responses in the ipsilateral thalamus of MCAO rats. Finally, bepridil treatment mitigated MCAO-induced alterations in APP processing in the ipsilateral thalamus and improved contralateral forelimb use in MCAO rats. These findings suggest that bepridil is a plausible therapeutic candidate in AD or stroke owing to its multifunctional role in key cellular events that are relevant for the pathogenesis of these diseases.

SUBMITTER: Sarajarvi T 

PROVIDER: S-EPMC4118244 | biostudies-literature | 2012 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bepridil decreases Aβ and calcium levels in the thalamus after middle cerebral artery occlusion in rats.

Sarajärvi Timo T   Lipsanen Anu A   Mäkinen Petra P   Peräniemi Sirpa S   Soininen Hilkka H   Haapasalo Annakaisa A   Jolkkonen Jukka J   Hiltunen Mikko M  

Journal of cellular and molecular medicine 20121101 11


Alzheimer's disease (AD) and cerebral ischaemia share similar features in terms of altered amyloid precursor protein (APP) processing and β-amyloid (Aβ) accumulation. We have previously shown that Aβ and calcium deposition, and β-secretase activity, are robustly increased in the ipsilateral thalamus after transient middle cerebral artery occlusion (MCAO) in rats. Here, we investigated whether the non-selective calcium channel blocker bepridil, which also inhibits β-secretase cleavage of APP, aff  ...[more]

Similar Datasets

| S-EPMC5527153 | biostudies-literature
| S-EPMC6513323 | biostudies-literature
| S-EPMC9326608 | biostudies-literature
| S-EPMC7794019 | biostudies-literature
| S-EPMC5786000 | biostudies-literature
| S-EPMC4976655 | biostudies-literature
| S-EPMC4916503 | biostudies-literature
| S-EPMC10412954 | biostudies-literature
2021-03-16 | GSE166162 | GEO
| S-EPMC6817403 | biostudies-literature